Results

Reset All Filters

Manufacturer:Selleckchem remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
Atezolizumab (anti-PD-L1)	Antibody	Other	A2004-1mg Selleckchem	1 mg	Login Compare	Atezolizumab (anti-PD-L1)
Pembrolizumab (anti-PD-1)	Antibody	Other	A2005-1mg Selleckchem	1 mg	Login Compare	Pembrolizumab (anti-PD-1)
Pembrolizumab (anti-PD-1)	Antibody	Other	A2005-25mg Selleckchem	1 mg x 25	Login Compare	Pembrolizumab (anti-PD-1)
Bevacizumab (anti-VEGF)	Inhibitors	Other	A2006-25mg Selleckchem	1 mg x 25	Login Compare	Bevacizumab (anti-VEGF)
Trastuzumab (anti-HER2)	Inhibitors	Other	A2007-25mg Selleckchem	1 mg x 25	Login Compare	Trastuzumab (anti-HER2)
Pertuzumab (anti-HER2)	Inhibitors	Other	A2008-1mg Selleckchem	1 mg	Login Compare	Pertuzumab (anti-HER2)
Pertuzumab (anti-HER2)	Inhibitors	Other	A2008-25mg Selleckchem	1 mg x 25	Login Compare	Pertuzumab (anti-HER2)
Rituximab (anti-CD20)	Inhibitors	Other	A2009-1mg Selleckchem	1 mg	Login Compare	Rituximab (anti-CD20)
Rituximab (anti-CD20)	Inhibitors	Other	A2009-25mg Selleckchem	1 mg x 25	Login Compare	Rituximab (anti-CD20)
Adalimumab (anti-TNF-alpha)	Inhibitors	Other	A2010-1mg Selleckchem	1 mg	Login Compare	Adalimumab (anti-TNF-alpha)
Adalimumab (anti-TNF-alpha)	Inhibitors	Other	A2010-25mg Selleckchem	1 mg x 25	Login Compare	Adalimumab (anti-TNF-alpha)
Sarilumab (anti-IL-6Rα)	Inhibitors	Other	A2011-1mg Selleckchem	1 mg	Login Compare	Sarilumab (anti-IL-6Rα)
Sarilumab (anti-IL-6Rα)	Inhibitors	Other	A2011-25mg Selleckchem	1 mg x 25	Login Compare	Sarilumab (anti-IL-6Rα)
Tocilizumab (anti-IL-6R)	Inhibitors	Other	A2012-1mg Selleckchem	1 mg	Login Compare	Tocilizumab (anti-IL-6R)
Tocilizumab (anti-IL-6R)	Inhibitors	Other	A2012-25mg Selleckchem	1 mg x 25	Login Compare	Tocilizumab (anti-IL-6R)
Durvalumab (anti-PD-L1)	Inhibitors	Other	A2013-1mg Selleckchem	1 mg	Login Compare	Durvalumab (anti-PD-L1)
Durvalumab (anti-PD-L1)	Inhibitors	Other	A2013-25mg Selleckchem	1 mg x 25	Login Compare	Durvalumab (anti-PD-L1)
Avelumab (anti-PD-L1)	Inhibitors	Other	A2015-1mg Selleckchem	1 mg	Login Compare	Avelumab (anti-PD-L1)
Camrelizumab (anti-PD-1)	Inhibitors	Other	A2016-1mg Selleckchem	1 mg	Login Compare	Camrelizumab (anti-PD-1)
Camrelizumab (anti-PD-1)	Inhibitors	Other	A2016-25mg Selleckchem	1 mg x 25	Login Compare	Camrelizumab (anti-PD-1)
Spartalizumab (anti-PD-1)	Inhibitors	Other	A2017-25mg Selleckchem	1 mg x 25	Login Compare	Spartalizumab (anti-PD-1)
Infliximab (anti-TNF-alpha)	Inhibitors	Other	A2019-1mg Selleckchem	1 mg	Login Compare	Infliximab (anti-TNF-alpha)
Infliximab (anti-TNF-alpha)	Inhibitors	Other	A2019-25mg Selleckchem	1 mg x 25	Login Compare	Infliximab (anti-TNF-alpha)
Obinutuzumab (anti-CD20)	Inhibitors	Other	A2023-1mg Selleckchem	1 mg	Login Compare	Obinutuzumab (anti-CD20)
Obinutuzumab (anti-CD20)	Inhibitors	Other	A2023-25mg Selleckchem	1 mg x 25	Login Compare	Obinutuzumab (anti-CD20)

Name Price

Atezolizumab (anti-PD-L1)

Type	Antibody
Clone
Specific against	Other
Appl.
Host
Item no.	A2004-1mg
Amount	1 mg
Available

Pembrolizumab (anti-PD-1)

Type	Antibody
Clone
Specific against	Other
Appl.
Host
Item no.	A2005-1mg
Amount	1 mg
Available

Pembrolizumab (anti-PD-1)

Type	Antibody
Clone
Specific against	Other
Appl.
Host
Item no.	A2005-25mg
Amount	1 mg x 25
Available

Bevacizumab (anti-VEGF)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2006-25mg
Amount	1 mg x 25
Available

Trastuzumab (anti-HER2)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2007-25mg
Amount	1 mg x 25
Available

Pertuzumab (anti-HER2)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2008-1mg
Amount	1 mg
Available

Pertuzumab (anti-HER2)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2008-25mg
Amount	1 mg x 25
Available

Rituximab (anti-CD20)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2009-1mg
Amount	1 mg
Available

Rituximab (anti-CD20)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2009-25mg
Amount	1 mg x 25
Available

Adalimumab (anti-TNF-alpha)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2010-1mg
Amount	1 mg
Available

Adalimumab (anti-TNF-alpha)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2010-25mg
Amount	1 mg x 25
Available

Sarilumab (anti-IL-6Rα)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2011-1mg
Amount	1 mg
Available

Sarilumab (anti-IL-6Rα)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2011-25mg
Amount	1 mg x 25
Available

Tocilizumab (anti-IL-6R)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2012-1mg
Amount	1 mg
Available

Tocilizumab (anti-IL-6R)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2012-25mg
Amount	1 mg x 25
Available

Durvalumab (anti-PD-L1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2013-1mg
Amount	1 mg
Available

Durvalumab (anti-PD-L1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2013-25mg
Amount	1 mg x 25
Available

Avelumab (anti-PD-L1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2015-1mg
Amount	1 mg
Available

Camrelizumab (anti-PD-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2016-1mg
Amount	1 mg
Available

Camrelizumab (anti-PD-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2016-25mg
Amount	1 mg x 25
Available

Spartalizumab (anti-PD-1)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2017-25mg
Amount	1 mg x 25
Available

Infliximab (anti-TNF-alpha)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2019-1mg
Amount	1 mg
Available

Infliximab (anti-TNF-alpha)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2019-25mg
Amount	1 mg x 25
Available

Obinutuzumab (anti-CD20)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2023-1mg
Amount	1 mg
Available

Obinutuzumab (anti-CD20)

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A2023-25mg
Amount	1 mg x 25
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk